ArticleClinical case reports2025
Miliary TB Without Microbiological Confirmation in a Post-Menopausal Female: A Case From a High-Burden Region.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Miliary TB Without Microbiological Confirmation in a Post-Menopausal Female: A Case From a High-Burden Region.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Miliary tuberculosis (TB) presents significant diagnostic challenges in resource-limited, high-burden regions when microbiological confirmation is unattainable. We describe a 65-year-old post-menopausal Nepalese woman with prolonged fever, anemia, and constitutional symptoms. Initial chest radiography was inconclusive, but contrast-enhanced computed tomography (CECT) revealed diffuse miliary nodules, calcified lymphadenopathy, and pleural effusion. Microbiological confirmation was precluded by the inability to expectorate and refusal of bronchoscopy. Empirical anti-TB therapy (isoniazid, rifampicin, pyrazinamide, and ethambutol) was initiated based on radiological findings and epidemiological context (Nepal TB prevalence: 245/100,000). The patient showed symptomatic and hematological improvement at follow-up despite declining invasive diagnostics. This case underscores CT imaging's critical role in diagnosing miliary TB when microbiological evidence is unavailable and supports ethical empirical treatment in elderly patients from endemic regions where diagnostic limitations exist.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.